Articles by James Calloway
Microchip Technology Shares Slip on Mixed Outlook and Analyst Views
Microchip Technology shares declined 2.6% Friday following its quarterly results and guidance, with analysts divided on the stock's path amid supply chain pressures.
SMIC Faces Key Earnings and Acquisition Vote in Busy Week Ahead
Semiconductor Manufacturing International Corp. will release unaudited financial results on Feb. 10, followed by a shareholder vote on Feb. 12 to acquire the remaining 49% stake in subsidiary SMNC.
MediaTek Shares Slide 3.4% Ahead of Holiday; Firm Doubles Data Center Investment
MediaTek shares fell 3.4% to NT$1,710 as markets closed for the weekend. The chip designer reported higher Q4 sales but lower net income, while announcing plans to double its investment in data center chips and advanced packaging.
ADI Director's Stock Sale Precedes Key Earnings, Economic Data
Analog Devices director Ray Stata sold 6,250 shares ahead of the company's fiscal Q1 report and upcoming U.S. payrolls and CPI data. ADI shares closed slightly lower Friday.
Deutsche Telekom Shares Dip Amid Buyback Activity Ahead of Key Earnings
Deutsche Telekom shares declined 1.1% to €30.26 despite a €7.63 million share repurchase, with investors focused on upcoming 2025 financial results due February 26.
Salesforce Recovers to $191 Amid AI Sector Rotation, Eyes Earnings
Salesforce shares stabilized at $191.35 Friday, paring weekly losses after an AI-driven selloff hit software stocks. Investors await Q4 results due Feb. 25.
CBA Shares Hold Ground Ahead of Key Earnings Report
Commonwealth Bank shares showed relative resilience, declining only 0.23% versus the broader ASX 200's 2.03% drop. Investors await the bank's half-year results and commentary on margin pressures and credit trends.
Abbott Faces Regulatory Scrutiny on Libre Sensors as Insider Buying and New AFib Data Emerge
Abbott shares rose 1.6% to $110.83 Friday but remain 21.5% below their 52-week high. The FDA updated a Class I recall for FreeStyle Libre 3 sensors, citing 860 serious injuries and seven deaths, while an insider purchased 10,000 shares.
Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure
Novo Nordisk's Class B shares surged 5.3% after Hims & Hers discontinued its compounded Wegovy pill following U.S. regulatory warnings. The stock had dropped nearly 8% when the copycat launched.
Linde Shares Slide on 2026 Guidance, JPMorgan Downgrade
Linde stock fell 2.5% after issuing 2026 EPS guidance below consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets.
T-Mobile Shares Dip Ahead of Key Financial Outlook and Earnings Report
T-Mobile US stock declined 2.2% to $197.39 Friday, underperforming the broader market as investors await the company's updated 2026-27 targets and Q4 earnings on Feb. 11.